Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer

References

• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267 - 96; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141609; PMID: 17134371
   PubMed Web of Science ®Google Scholar
• Pekarek LA, Starr BA, Toledano AY, Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J Exp Med 1995; 181:435 - 40; http://dx.doi.org/10.1084/jem.181.1.435; PMID: 7807024
   PubMed Web of Science ®Google Scholar
• Seung LP, Rowley DA, Dubey P, Schreiber H. Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc Natl Acad Sci U S A 1995; 92:6254 - 8; http://dx.doi.org/10.1073/pnas.92.14.6254; PMID: 7603979
   PubMed Web of Science ®Google Scholar
• Seung LP, Seung SK, Schreiber H. Antigenic cancer cells that escape immune destruction are stimulated by host cells. Cancer Res 1995; 55:5094 - 100; PMID: 7585557
   PubMed Web of Science ®Google Scholar
• Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004; 64:7022 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-04-1449; PMID: 15466195
   PubMed Web of Science ®Google Scholar
• Singh S, Ross SR, Acena M, Rowley DA, Schreiber H. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med 1992; 175:139 - 46; http://dx.doi.org/10.1084/jem.175.1.139; PMID: 1309851
   PubMed Web of Science ®Google Scholar
• Spiotto MT, Yu P, Rowley DA, Nishimura MI, Meredith SC, Gajewski TF, Fu YX, Schreiber H. Increasing tumor antigen expression overcomes “ignorance” to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002; 17:737 - 47; http://dx.doi.org/10.1016/S1074-7613(02)00480-6; PMID: 12479820
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162 - 74; http://dx.doi.org/10.1038/nri2506; PMID: 19197294
   PubMed Web of Science ®Google Scholar
• Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008; 40:650 - 5; http://dx.doi.org/10.1038/ng.117; PMID: 18408720
   PubMed Web of Science ®Google Scholar
• Chometon G, Jendrossek V. Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy. Clin Transl Oncol 2009; 11:75 - 81; http://dx.doi.org/10.1007/s12094-009-0317-y; PMID: 19211371
   PubMed Web of Science ®Google Scholar
• Spiotto MT, Rowley DA, Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nat Med 2004; 10:294 - 8; http://dx.doi.org/10.1038/nm999; PMID: 14981514
   PubMed Web of Science ®Google Scholar
• Zhang B, Bowerman NA, Salama JK, Schmidt H, Spiotto MT, Schietinger A, Yu P, Fu YX, Weichselbaum RR, Rowley DA, et al. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med 2007; 204:49 - 55; http://dx.doi.org/10.1084/jem.20062056; PMID: 17210731
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Bowerman NA, Schietinger A, Fu YX, Kranz DM, Rowley DA, Schreiber H. Equilibrium between host and cancer caused by effector T cells killing tumor stroma. Cancer Res 2008; 68:1563 - 71; http://dx.doi.org/10.1158/0008-5472.CAN-07-5324; PMID: 18316622
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009; 19:43 - 51; http://dx.doi.org/10.1016/j.tcb.2008.11.003; PMID: 19144520
   PubMed Web of Science ®Google Scholar
• Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9:581 - 93; http://dx.doi.org/10.1038/nri2567; PMID: 19498381
   PubMed Web of Science ®Google Scholar
• Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002; 360:295 - 305; http://dx.doi.org/10.1016/S0140-6736(02)09552-1; PMID: 12147373
   PubMed Web of Science ®Google Scholar
• Neijssen J, Herberts C, Drijfhout JW, Reits E, Janssen L, Neefjes J. Cross-presentation by intercellular peptide transfer through gap junctions. Nature 2005; 434:83 - 8; http://dx.doi.org/10.1038/nature03290; PMID: 15744304
   PubMed Web of Science ®Google Scholar
• Groothuis TA, Neefjes J. The many roads to cross-presentation. J Exp Med 2005; 202:1313 - 8; http://dx.doi.org/10.1084/jem.20051379; PMID: 16287713
   PubMed Web of Science ®Google Scholar
• Zhang B, Karrison T, Rowley DA, Schreiber H. IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers. J Clin Invest 2008; 118:1398 - 404; http://dx.doi.org/10.1172/JCI33522; PMID: 18317595
   PubMed Web of Science ®Google Scholar
• Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 2007; 204:345 - 56; http://dx.doi.org/10.1084/jem.20061890; PMID: 17261634
   PubMed Web of Science ®Google Scholar
• Boissonnas A, Scholer-Dahire A, Fetler L, Amigorena S. Multiphoton imaging of cytotoxic T lymphocyte-mediated antitumor immune responses. Curr Top Microbiol Immunol 2009; 334:265 - 87; http://dx.doi.org/10.1007/978-3-540-93864-4_11; PMID: 19521689
   PubMed Web of Science ®Google Scholar
• Breart B, Lemaître F, Celli S, Bousso P. Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 2008; 118:1390 - 7; http://dx.doi.org/10.1172/JCI34388; PMID: 18357341
   PubMed Web of Science ®Google Scholar
• Pittet MJ, Grimm J, Berger CR, Tamura T, Wojtkiewicz G, Nahrendorf M, Romero P, Swirski FK, Weissleder R. In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A 2007; 104:12457 - 61; http://dx.doi.org/10.1073/pnas.0704460104; PMID: 17640914
   PubMed Web of Science ®Google Scholar
• Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A, Cavanagh LL, von Andrian UH, Ertl HC, Haydon PG, et al. Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 2006; 203:2749 - 61; http://dx.doi.org/10.1084/jem.20060710; PMID: 17116735
   PubMed Web of Science ®Google Scholar
• Pittet MJ. Behavior of immune players in the tumor microenvironment. Curr Opin Oncol 2009; 21:53 - 9; http://dx.doi.org/10.1097/CCO.0b013e32831bc38a; PMID: 19125019
   PubMed Web of Science ®Google Scholar
• Lohela M, Werb Z. Intravital imaging of stromal cell dynamics in tumors. Curr Opin Genet Dev 2010; 20:72 - 8; http://dx.doi.org/10.1016/j.gde.2009.10.011; PMID: 19942428
   PubMed Web of Science ®Google Scholar
• Zal T, Chodaczek G. Intravital imaging of anti-tumor immune response and the tumor microenvironment. Semin Immunopathol 2010; 32:305 - 17; http://dx.doi.org/10.1007/s00281-010-0217-9; PMID: 20652252
   PubMed Web of Science ®Google Scholar
• Germain RN, Miller MJ, Dustin ML, Nussenzweig MC. Dynamic imaging of the immune system: progress, pitfalls and promise. Nat Rev Immunol 2006; 6:497 - 507; http://dx.doi.org/10.1038/nri1884; PMID: 16799470
   PubMed Web of Science ®Google Scholar
• Ryan GB, Majno G. Acute inflammation. A review. Am J Pathol 1977; 86:183 - 276; PMID: 64118
   PubMed Web of Science ®Google Scholar
• Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6:173 - 82; http://dx.doi.org/10.1038/nri1785; PMID: 16498448
   PubMed Web of Science ®Google Scholar
• Algire GH. An adaptation of the transparent chamber technique to the mouse. J Natl Cancer Inst 1943; 4:1 - 11
   Google Scholar
• Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 1988; 335:271 - 4; http://dx.doi.org/10.1038/335271a0; PMID: 3261843
   PubMed Web of Science ®Google Scholar
• Udaka K, Wiesmüller KH, Kienle S, Jung G, Walden P. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol 1996; 157:670 - 8; PMID: 8752916
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49:6449 - 65; PMID: 2684393
   PubMed Web of Science ®Google Scholar
• Patterson G, Day RN, Piston D. Fluorescent protein spectra. J Cell Sci 2001; 114:837 - 8; PMID: 11181166
   PubMed Web of Science ®Google Scholar
• Hadjantonakis AK, Nagy A. The color of mice: in the light of GFP-variant reporters. Histochem Cell Biol 2001; 115:49 - 58; PMID: 11219608
   PubMed Web of Science ®Google Scholar
• Rizzo MA, Springer GH, Granada B, Piston DW. An improved cyan fluorescent protein variant useful for FRET. Nat Biotechnol 2004; 22:445 - 9; http://dx.doi.org/10.1038/nbt945; PMID: 14990965
   PubMed Web of Science ®Google Scholar
• Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 2004; 40:241 - 6; http://dx.doi.org/10.1002/gene.20095; PMID: 15593332
   PubMed Web of Science ®Google Scholar
• Engels B, Engelhard VH, Sidney J, Sette A, Binder DC, Liu RB, Kranz DM, Meredith SC, Rowley DA, Schreiber H. Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell 2013; 23:516 - 26; http://dx.doi.org/10.1016/j.ccr.2013.03.018; PMID: 23597565
   PubMed Web of Science ®Google Scholar
• Papenfuss HD, Gross JF, Intaglietta M, Treese FA. A transparent access chamber for the rat dorsal skin fold. Microvasc Res 1979; 18:311 - 8; http://dx.doi.org/10.1016/0026-2862(79)90039-6; PMID: 537508
   PubMed Web of Science ®Google Scholar
• Huang Q, Shan S, Braun RD, Lanzen J, Anyrhambatla G, Kong G, Borelli M, Corry P, Dewhirst MW, Li CY. Noninvasive visualization of tumors in rodent dorsal skin window chambers. Nat Biotechnol 1999; 17:1033 - 5; http://dx.doi.org/10.1038/13736; PMID: 10504711
   PubMed Web of Science ®Google Scholar
• Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008; 222:162 - 79; http://dx.doi.org/10.1111/j.1600-065X.2008.00602.x; PMID: 18364001
   PubMed Web of Science ®Google Scholar
• Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2006; 16:53 - 65; http://dx.doi.org/10.1016/j.semcancer.2005.07.005; PMID: 16168663
   PubMed Web of Science ®Google Scholar
• Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006; 42:717 - 27; http://dx.doi.org/10.1016/j.ejca.2006.01.003; PMID: 16520032
   PubMed Web of Science ®Google Scholar
• Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392 - 401; http://dx.doi.org/10.1038/nrc1877; PMID: 16572188
   PubMed Web of Science ®Google Scholar
• Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006; 5:1597 - 601; http://dx.doi.org/10.4161/cc.5.15.3112; PMID: 16880743
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432:332 - 7; http://dx.doi.org/10.1038/nature03096; PMID: 15549095
   PubMed Web of Science ®Google Scholar
• Noonan DM, De Lerma Barbaro A, Vannini N, Mortara L, Albini A. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 2008; 27:31 - 40; http://dx.doi.org/10.1007/s10555-007-9108-5; PMID: 18087678
   PubMed Web of Science ®Google Scholar
• Purhonen S, Palm J, Rossi D, Kaskenpää N, Rajantie I, Ylä-Herttuala S, Alitalo K, Weissman IL, Salven P. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008; 105:6620 - 5; http://dx.doi.org/10.1073/pnas.0710516105; PMID: 18443294
   PubMed Web of Science ®Google Scholar
• Lieberman J. Cell-Mediated Cytotoxicity in Fundamental Immunology., W. Paul, Editor. 2013, Paul, W., Lippincott-Williams & Wilkins: Philadelphia, PA. p. 891-909.
   Google Scholar
• Kamoun WS, Chae SS, Lacorre DA, Tyrrell JA, Mitre M, Gillissen MA, Fukumura D, Jain RK, Munn LL. Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks. Nat Methods 2010; 7:655 - 60; http://dx.doi.org/10.1038/nmeth.1475; PMID: 20581828
   PubMed Web of Science ®Google Scholar
• Khong HT, Wang QJ, Rosenberg SA. Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother 2004; 27:184 - 90; http://dx.doi.org/10.1097/00002371-200405000-00002; PMID: 15076135
   PubMed Web of Science ®Google Scholar
• Lehmann F, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, Boon T, Coulie PG. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 1995; 25:340 - 7; http://dx.doi.org/10.1002/eji.1830250206; PMID: 7875194
   PubMed Web of Science ®Google Scholar
• Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci U S A 2002; 99:16168 - 73; http://dx.doi.org/10.1073/pnas.242600099; PMID: 12427970
   PubMed Web of Science ®Google Scholar
• Sanderson NS, Puntel M, Kroeger KM, Bondale NS, Swerdlow M, Iranmanesh N, Yagita H, Ibrahim A, Castro MG, Lowenstein PR. Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells. Proc Natl Acad Sci U S A 2012; 109:7835 - 40; http://dx.doi.org/10.1073/pnas.1116058109; PMID: 22547816
   PubMed Web of Science ®Google Scholar
• Blohm U, Potthoff D, van der Kogel AJ, Pircher H. Solid tumors “melt” from the inside after successful CD8 T cell attack. Eur J Immunol 2006; 36:468 - 77; http://dx.doi.org/10.1002/eji.200526175; PMID: 16385625
   PubMed Web of Science ®Google Scholar
• Gerbitz A, Sukumar M, Helm F, Wilke A, Friese C, Fahrenwaldt C, Lehmann FM, Loddenkemper C, Kammertoens T, Mautner J, et al. Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice. PLoS One 2012; 7:e34552; http://dx.doi.org/10.1371/journal.pone.0034552; PMID: 22479645
   PubMedGoogle Scholar
• Briesemeister D, Sommermeyer D, Loddenkemper C, Loew R, Uckert W, Blankenstein T, Kammertoens T. Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. Int J Cancer 2011; 128:371 - 8; http://dx.doi.org/10.1002/ijc.25350; PMID: 20333679
   PubMed Web of Science ®Google Scholar
• Listopad JJ, Kammertoens T, Anders K, Silkenstedt B, Willimsky G, Schmidt K, Kuehl AA, Loddenkemper C, Blankenstein T. Fas expression by tumor stroma is required for cancer eradication. Proc Natl Acad Sci U S A 2013; 110:2276 - 81; http://dx.doi.org/10.1073/pnas.1218295110; PMID: 23341634
   PubMed Web of Science ®Google Scholar
• Urban JL, Shepard HM, Rothstein JL, Sugarman BJ, Schreiber H. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci U S A 1986; 83:5233 - 7; http://dx.doi.org/10.1073/pnas.83.14.5233; PMID: 3487788
   PubMed Web of Science ®Google Scholar
• Thilenius AR, Sabelko-Downes KA, Russell JH. The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: potential in vivo function of Fas in experimental allergic encephalomyelitis. J Immunol 1999; 162:643 - 50; PMID: 9916681
   PubMed Web of Science ®Google Scholar
• Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993; 90:8392 - 6; http://dx.doi.org/10.1073/pnas.90.18.8392; PMID: 7690960
   PubMed Web of Science ®Google Scholar
• Algire GH, Legallais FY. Recent developments in the transparent-chamber technique as adapted to the mouse. J Natl Cancer Inst 1949; 10:225 - 53, 8; PMID: 15393709
   PubMed Web of Science ®Google Scholar
• Li Y, Song Y, Zhao L, Gaidosh G, Laties AM, Wen R. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protoc 2008; 3:1703 - 8; http://dx.doi.org/10.1038/nprot.2008.172; PMID: 18846097
   PubMed Web of Science ®Google Scholar